Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Not Yet Recruiting Phase 1 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0093202 (Ann Arbor Stage II Diffuse Large B-Cell Lymphoma)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs